6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	SFG Quarterly Activities/Appendix 4CCash Flow Report
Just now	BSA Announces On-Market Share Buy-Back
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C

About

Scynexis Inc (NASDAQ:SCYX) — investor relations, events, news, and company updates on 6ix.

Latest News

SCYNEXIS Announces $40.0 Million Private Placement

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million

SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247

Financials

Revenue

$20.6 M

Market Cap

$39.66 M

EPS

-0.17

Community Chat

Ask AI